GRK 3 Antibody (C-11): sc-365197

GRK 3 Antibody (C-11) is a mouse monoclonal IgG1 kappa light chain antibody that detects GRK 3 protein of mouse, rat, and human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). GRK 3 (C-11) antibody is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. GRK 3, also known as β-adrenergic receptor kinase 2, plays a crucial role in regulating G protein-coupled receptor signaling by phosphorylating activated receptors, leading to their desensitization. This process maintains cellular responsiveness to external signals by preventing overstimulation and allowing fine-tuning of physiological responses. GRK 3 is particularly important for cardiovascular health, modulating signaling pathways of adrenergic receptors essential for heart function. Dysregulation of GRK 3 activity has been implicated in various cardiovascular diseases, making GRK 3 a significant target for therapeutic intervention. Through interactions with multiple receptor types, GRK 3 serves as a key player in cellular signaling networks, highlighting anti-GRK 3 antibody (C-11)′s importance in research and clinical applications.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

GRK 3 Antibody (C-11) References:

1. The receptor kinase family: primary structure of rhodopsin kinase reveals similarities to the beta-adrenergic receptor kinase.  |  Lorenz, W., et al. 1991. Proc Natl Acad Sci U S A. 88: 8715-9. PMID: 1656454
2. Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family.  |  Benovic, JL., et al. 1991. J Biol Chem. 266: 14939-46. PMID: 1869533
3. Turning off the signal: desensitization of beta-adrenergic receptor function.  |  Hausdorff, WP., et al. 1990. FASEB J. 4: 2881-9. PMID: 2165947
4. GRK3 deficiency elicits brain immune activation and psychosis.  |  Sellgren, CM., et al. 2021. Mol Psychiatry. 26: 6820-6832. PMID: 33976392
5. GRK3 as a Prognosis Biomarker in Gastric Cancer.  |  Fang, CL., et al. 2022. J Cancer. 13: 1299-1306. PMID: 35281865
6. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.  |  Li, Y., et al. 2022. J Exp Clin Cancer Res. 41: 257. PMID: 35996148
7. Distinct Role of GRK3 in Platelet Activation by Desensitization of G Protein-Coupled Receptors.  |  Chaudhary, PK., et al. 2024. Thromb Haemost.. PMID: 39419098
8. Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases.  |  Premont, RT., et al. 1994. J Biol Chem. 269: 6832-41. PMID: 8120045
9. An approach to the study of G-protein-coupled receptor kinases: an in vitro-purified membrane assay reveals differential receptor specificity and regulation by G beta gamma subunits.  |  Pei, G., et al. 1994. Proc Natl Acad Sci U S A. 91: 3633-6. PMID: 8170959
10. Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase.  |  Inglese, J., et al. 1994. Proc Natl Acad Sci U S A. 91: 3637-41. PMID: 8170960
11. Structure and mechanism of the G protein-coupled receptor kinases.  |  Inglese, J., et al. 1993. J Biol Chem. 268: 23735-8. PMID: 8226899
12. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.  |  Liggett, SB., et al. 1993. Proc Natl Acad Sci U S A. 90: 3665-9. PMID: 8386380

Monoclonal antibodies for mammalian and non-mammalian protein targets represent essentially all targets covered by polyclonal antibodies. Over 8,300 of our antibodies are offered as ImmunoCruz^® conjugates which eliminates the need for a secondary antibody.

Santa Cruz Biotechnology antibodies have over 360,000 research citations. Anti-GRK 3 Antibody (C-11) has 3 citations in a variety of scientific publications.

Primary antibodies like Anti-GRK 3 Antibody (C-11) for mammalian target proteins are recommended for the detection of a range of mammalian species, primarily of mouse, rat and human species. Many mammalian antibodies are also ideal for veterinary research and reactive with ovine, porcine, caprine, feline, canine, bovine and equine protein targets. Santa Cruz Biotechnology primary monoclonal antibodies are suitable for laboratory research applications and are not intended for diagnostic or therapeutic use.

GRK 3 Antibody (C-11) Specifications

Alternate Product Name: GRK3

Product Clone Name: C-11

Classification: Primary Antibody

Clonality: Monoclonal Antibody

Antibody Isotype: IgG₁ kappa light chain

Amino Acids: 646-688

Epitope Target: GRK 3

Epitope Species: human

Product Reactivity/Detection: GRK 3

Species Reactivity/Detection: mouse, rat, human

Additional Mammalian Reactivity: N/A

Additional Non-Mammalian Reactivity: N/A

Applications: WB, IP, IF, ELISA

Vialing Information: Each vial contains 200 µg IgG₁ kappa light chain in 1.0 ml of PBS with < 0.1% sodium azide and 0.1% gelatin

Research Citations: 3 citations in various scientific publications

Available Conjugates/Forms for GRK 3 Antibody (C-11): AC: Agarose, AF488: Alexa Fluor^® 488, AF546: Alexa Fluor^® 546, AF594: Alexa Fluor^® 594, AF647: Alexa Fluor^® 647, AF680: Alexa Fluor^® 680, AF790: Alexa Fluor^® 790, FITC: Fluoroscein, HRP: Horseradish Peroxidase, PE: Phycoerythrin